Institutional Ownership Sab Biotherapeutics Inc Wt Exp (SABSW)
This table provides information about the institutional ownership of Sab Biotherapeutics Inc Wt Exp (SABSW). We have compiled data on the 11 institutions that hold shares in the stock, with a total of 879,429 shares, which have been reported (via 13F filing form) to have a value of $26,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Lmr Partners LLP
London, X0 |
Feb 14, 2025 Q4 2024 |
539,588
shares
|
$16,187
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
146,439
shares
|
$4,393
0.0% of portfolio
|
Q2 2024
Reduced 1.68%
|
|
|
Yakira Capital Management, Inc.
Westport, CT |
Feb 13, 2025 Q4 2024 |
93,230
shares
|
$2,796
0.0% of portfolio
|
Q4 2024
Reduced 14.06%
|
|
|
Hb Wealth Management, LLC
|
Jan 15, 2025 Q4 2024 |
50,001
shares
|
$1,500
0.0% of portfolio
|
Q4 2024
Reduced 83.87%
|
|
|
Walleye Trading LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
38,763
shares
|
$1,162
0.0% of portfolio
|
Q4 2024
Added 150.0%
|
|
|
Wolverine Asset Management LLC
|
Feb 03, 2025 Q4 2024 |
8,655
shares
|
$259
0.0% of portfolio
|
Q4 2024
Reduced 44.23%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,633
shares
|
$48
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Feb 13, 2025 Q4 2024 |
1,072
shares
|
$32
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
48
shares
|
$1
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|